Fig. 2: Cumulative incidence of NRM, RI, neutrophil engraftment and GRFS by ATG and PTCY.

Non relapse mortality (1), relapse incidence (2), neutrophil engraftment (3) and GRFS (4) in ATG ATG (continuous line) and PTCY (dashed line) group.

Non relapse mortality (1), relapse incidence (2), neutrophil engraftment (3) and GRFS (4) in ATG ATG (continuous line) and PTCY (dashed line) group.